<p>cMP levels in the 44 non-CVD controls and the 44 patients at the onset of stroke.</p
<p>Plasma levels of TIMPs, CRP and I-FABP during follow-up of 3 patient groups.</p
<p>Cox regressions of MMP-9 in relation to a composite measure of CHD-events and cerebral infarction...
Baseline characteristics in patients with stroke (n = 48) and healthy controls (n = 46).</p
<p>Each box indicates the median. Horizontal lines indicate the interquartile ranges. D1, within 12 ...
<p>n (%) value</p><p><i>CMBs</i> cerebral microbleeds</p><p>Frequency of CMBs according to presence ...
Background: The presence of C-reactive protein (CRP) during different stages of stroke had been show...
<p>Analysis of Hs-CRP levels (ng/ml) in Coronary Artery Disease (CAD) patients, FDRS and Controls.</...
<p>cMPs at the onset of stoke and after 7 and 90 days in the 44 patients included in the study.</p
Clinical and CMR characteristics in patients with non-ischemic cardiomyopathy vs the control cohort....
<p>Each box indicates the median. Horizontal lines indicate the interquartile ranges. (<b>C</b>) Dia...
Aims: The aim of the study was to evaluate CRP and risk factors for ischemic stroke. Methods: This ...
<p>D1, within 12 hours of symptom onset; D2, 18–24 hours from baseline (D1); CRP, C-reactive protein...
BACKGROUND AND OBJECTIVE: Elevated CRP level is independently associated with the excessive risk of ...
Background—Current guidelines recommend the assessment of C-reactive protein (CRP) levels with a hig...
<p>Open markers indicate serially analyzed protein levels in each patient. Each box indicates the me...
<p>Plasma levels of TIMPs, CRP and I-FABP during follow-up of 3 patient groups.</p
<p>Cox regressions of MMP-9 in relation to a composite measure of CHD-events and cerebral infarction...
Baseline characteristics in patients with stroke (n = 48) and healthy controls (n = 46).</p
<p>Each box indicates the median. Horizontal lines indicate the interquartile ranges. D1, within 12 ...
<p>n (%) value</p><p><i>CMBs</i> cerebral microbleeds</p><p>Frequency of CMBs according to presence ...
Background: The presence of C-reactive protein (CRP) during different stages of stroke had been show...
<p>Analysis of Hs-CRP levels (ng/ml) in Coronary Artery Disease (CAD) patients, FDRS and Controls.</...
<p>cMPs at the onset of stoke and after 7 and 90 days in the 44 patients included in the study.</p
Clinical and CMR characteristics in patients with non-ischemic cardiomyopathy vs the control cohort....
<p>Each box indicates the median. Horizontal lines indicate the interquartile ranges. (<b>C</b>) Dia...
Aims: The aim of the study was to evaluate CRP and risk factors for ischemic stroke. Methods: This ...
<p>D1, within 12 hours of symptom onset; D2, 18–24 hours from baseline (D1); CRP, C-reactive protein...
BACKGROUND AND OBJECTIVE: Elevated CRP level is independently associated with the excessive risk of ...
Background—Current guidelines recommend the assessment of C-reactive protein (CRP) levels with a hig...
<p>Open markers indicate serially analyzed protein levels in each patient. Each box indicates the me...
<p>Plasma levels of TIMPs, CRP and I-FABP during follow-up of 3 patient groups.</p
<p>Cox regressions of MMP-9 in relation to a composite measure of CHD-events and cerebral infarction...
Baseline characteristics in patients with stroke (n = 48) and healthy controls (n = 46).</p
DOI
Add to ORKG